Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SLC28A1 | O00337 | 1/20 | 0.42 |
| ▸ | SLC28A2 | O43868 | 1/20 | 0.42 |
| ▸ | SLC29A1 | Q99808 | 1/20 | 0.42 |
| ▸ | SLC28A3 | Q9HAS3 | 1/20 | 0.42 |
| ▸ | P2RY14 | Q15391 | 3/20 | 0.34 |
| ▸ | P2RY2 | P41231 | 4/20 | 0.32 |
| ▸ | P2RY4 | P51582 | 3/20 | 0.32 |
| ▸ | P2RY6 | Q15077 | 6/20 | 0.31 |
| ▸ | CRBN | Q96SW2 | 1/20 | 0.31 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.31 |
| ▸ | LMNA | P02545 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2337871 | 0.85 | SLC28A1 (0.41) | SLC28A1SLC28A2SLC29A1SLC28A3P2RY14 | |
| SCHEMBL2337859 | 0.85 | SLC28A1 (0.41) | SLC28A1SLC28A2SLC29A1SLC28A3P2RY14 | |
| SCHEMBL60518 | 0.82 | SLC28A1 (0.39) | SLC28A1SLC28A2SLC29A1SLC28A3P2RY14 | |
| SCHEMBL4259316 | 0.81 | SLC28A1 (0.38) | SLC28A1SLC28A2SLC29A1SLC28A3 | |
| SCHEMBL30286899 | 0.81 | SLC28A1 (0.36) | SLC28A1SLC28A2SLC29A1SLC28A3P2RY14 | |
| SCHEMBL4653180 | 0.81 | TK1 (0.40) | ALDH1A1LMNA | |
| SCHEMBL851503 | 0.80 | SLC28A1 (0.39) | SLC28A1SLC28A2SLC29A1SLC28A3P2RY14 | |
| SCHEMBL31000081 | 0.80 | SLC28A1 (0.37) | SLC28A1SLC28A2SLC29A1SLC28A3P2RY14 | |
| SCHEMBL29084627 | 0.79 | SLC28A1 (0.42) | SLC28A1SLC28A2SLC29A1SLC28A3P2RY14 | |
| Uridine SCHEMBL1347808 | 0.79 | SLC28A1 (0.56) | SLC28A1SLC28A2SLC29A1SLC28A3P2RY14 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1402071-A4 | METHODS AND PRODUCTS FOR ANALYZING NUCLEIC ACIDS BASED ON METHYLATION STATUS | US GENOMICS INC (US) | 2005-12-14 | — | — | EP | disclosed |
| EP-1402071-A2 | METHODS AND PRODUCTS FOR ANALYZING NUCLEIC ACIDS BASED ON METHYLATION STATUS | U.S. Genomics, Inc. (US) | 2004-03-31 | — | — | EP | disclosed |
| WO-2002101353-A2 | METHODS AND PRODUCTS FOR ANALYZING NUCLEIC ACIDS BASED ON METHYLATION STATUS | U.S. GENOMICS, INC. (US) | 2002-12-19 | — | — | WO | disclosed |